These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 25938717)
1. Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease. Vacca O; El Mathari B; Darche M; Sahel JA; Rendon A; Dalkara D J Vis Exp; 2015 Apr; (98):. PubMed ID: 25938717 [TBL] [Abstract][Full Text] [Related]
2. AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers. Vacca O; Darche M; Schaffer DV; Flannery JG; Sahel JA; Rendon A; Dalkara D Glia; 2014 Mar; 62(3):468-76. PubMed ID: 24382652 [TBL] [Abstract][Full Text] [Related]
3. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia. Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850 [TBL] [Abstract][Full Text] [Related]
4. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism. Woodard KT; Liang KJ; Bennett WC; Samulski RJ J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418 [TBL] [Abstract][Full Text] [Related]
5. Suppression of inner blood-retinal barrier breakdown and pathogenic Müller glia activation in ischemia retinopathy by myeloid cell depletion. Zhou L; Xu Z; Lu H; Cho H; Xie Y; Lee G; Ri K; Duh EJ J Neuroinflammation; 2024 Aug; 21(1):210. PubMed ID: 39182142 [TBL] [Abstract][Full Text] [Related]
6. Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in Boon N; Alves CH; Mulder AA; Andriessen CA; Buck TM; Quinn PMJ; Vos RM; Koster AJ; Jost CR; Wijnholds J Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808129 [TBL] [Abstract][Full Text] [Related]
8. SubILM Injection of AAV for Gene Delivery to the Retina. Gamlin PD; Alexander JJ; Boye SL; Witherspoon CD; Boye SE Methods Mol Biol; 2019; 1950():249-262. PubMed ID: 30783978 [TBL] [Abstract][Full Text] [Related]
9. Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina. Nicchia GP; Pisani F; Simone L; Cibelli A; Mola MG; Dal Monte M; Frigeri A; Bagnoli P; Svelto M Exp Eye Res; 2016 May; 146():259-268. PubMed ID: 27018215 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908 [TBL] [Abstract][Full Text] [Related]
11. AAV-mediated gene therapy in Dystrophin-Dp71 deficient mouse leads to blood-retinal barrier restoration and oedema reabsorption. Vacca O; Charles-Messance H; El Mathari B; Sene A; Barbe P; Fouquet S; Aragón J; Darche M; Giocanti-Aurégan A; Paques M; Sahel JA; Tadayoni R; Montañez C; Dalkara D; Rendon A Hum Mol Genet; 2016 Jul; 25(14):3070-3079. PubMed ID: 27288449 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic preretinal glia in aging and age-related macular degeneration. Edwards MM; McLeod DS; Bhutto IA; Villalonga MB; Seddon JM; Lutty GA Exp Eye Res; 2016 Sep; 150():44-61. PubMed ID: 26220834 [TBL] [Abstract][Full Text] [Related]
14. Newly-established in vitro inner BRB spheroids to elucidate retinal Ang2-linked substance transfer. Yamamoto Y; Akanuma SI; Kon H; Endo H; Kubo Y; Hosoya KI J Control Release; 2022 Nov; 351():8-21. PubMed ID: 36122894 [TBL] [Abstract][Full Text] [Related]
15. AAV-mediated, optogenetic ablation of Müller Glia leads to structural and functional changes in the mouse retina. Byrne LC; Khalid F; Lee T; Zin EA; Greenberg KP; Visel M; Schaffer DV; Flannery JG PLoS One; 2013; 8(9):e76075. PubMed ID: 24086689 [TBL] [Abstract][Full Text] [Related]
16. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors. Boye SL; Bennett A; Scalabrino ML; McCullough KT; Van Vliet K; Choudhury S; Ruan Q; Peterson J; Agbandje-McKenna M; Boye SE J Virol; 2016 Apr; 90(8):4215-4231. PubMed ID: 26865709 [TBL] [Abstract][Full Text] [Related]
17. Zika virus infection of cellular components of the blood-retinal barriers: implications for viral associated congenital ocular disease. Roach T; Alcendor DJ J Neuroinflammation; 2017 Mar; 14(1):43. PubMed ID: 28253931 [TBL] [Abstract][Full Text] [Related]
18. The Blood-Retinal Barrier in the Management of Retinal Disease: EURETINA Award Lecture. Cunha-Vaz J Ophthalmologica; 2017; 237(1):1-10. PubMed ID: 28152535 [TBL] [Abstract][Full Text] [Related]
19. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Dalkara D; Kolstad KD; Caporale N; Visel M; Klimczak RR; Schaffer DV; Flannery JG Mol Ther; 2009 Dec; 17(12):2096-102. PubMed ID: 19672248 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. Zhong X; Huang H; Shen J; Zacchigna S; Zentilin L; Giacca M; Vinores SA Mol Vis; 2011 Feb; 17():492-507. PubMed ID: 21364963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]